From the whole plants of Gentiana olivieri, three new bitter secoiridoid glycosides, olivierosides A (1), B (2) and C (3) were isolated together with the known compounds, gentiopicroside, sweroside, 6-O-b b-D-glucosylgentiopicroside, swertiapunimarin, eustomoside, eustomorusside and septemfidoside, and the structures of the new compounds were elucidated based on spectroscopic and chemical evidence.
Gentiana olivieri GRIESEB.(Gentianaceae) is used as a bitter tonic, stomachic and stimulant of appetite in traditional medicine in Turkey.
1) The plant is also used for diarrhea, common cold, stomachache, wound and ease of digestion in the Uzbekistan Republic.
2) Several alkaloids, 3) iridoid and secoiridoid glucosides, 4) and flavonoid glycosides 4) are known to be constituents. During the course of studies on the constituents of medicinal plants grown in the Uzbekistan Republic, we examined the glycosidic constituents of the title plant and isolated ten compounds, three of which are new bitter compounds termed olivierosides A (1), B (2) and C (3). This paper deals with the isolation and structural elucidation of these new compounds.
Compound 1 and 2 were isolated from the EtOAc soluble fraction and 3 was isolated from the water soluble fraction together with gentiopicro-side (4), 5) 6Ј-O-b-D-glucosylgentiopicroside, 6 ) sweroside (5), 7) swertiapunimarin, 8) eustomoside, 9) eustomorusside 9) and septemfidoside 10) by combination of several chromatographies including highly porous synthetic resin Diaion HP-20, silica gel and reversed phase HPLC as described in the Experimental section.
Compound 1 was obtained as an amorphous powder, [a] D Ϫ224°(MeOH) and the molecular formula was determined as C 25 H 26 O 11 on the basis of its high resolution (HR) FAB-MS. The 1 H-and 13 C-( Table 1) NMR spectra of the aglycone part were essentially the same as those of 4. The location of the acyl group was found to be at C-2Ј-O from comparisons of the 13 C-NMR spectra of 1 and 4. The signal due to C-2Ј underwent a downfield shift by 4 ppm and those of C-1Ј and C-3Ј suffered upfield shifts by 2.7 (or 2.3) and 2.4 ppm, respectively. Thus, the structure of 1 is represented as shown in the Formulae. (6) 11) was obtained on enzymatic hydrolysis, the structure was presumed to be b-D-glucopyranosylgentiopicroside. The connection of an additional b-D-glucopyranosyl unit to the original b-Dglucose unit of 4 was suggested to be on 3Ј-O by comparisons of 13 C-NMR data of 1 and b-laminaribiose 12) and was confirmed by interpretation of 1 H-1 H correlated spectroscopy (COSY) spectrum of the heptaacetate (3a) obtained by usual acetylation with acetic anhydride and pyridine. Thus, the signal [d H 3.89 (1H, t, Jϭ9.6 Hz)] which suffered no downfield shift crossed peaks with the signal at d H 4.92 (H-2Ј) which then crossed peaks with an anomeric proton (d H 4.73). Based on the above findings, the structure of 3 was elucidated as 3Ј-O-b-D-glucopyranosylgentiopicroside.
Experimental
Melting points were determined with a Yanagimoto micro-melting point apparatus and are uncorrected.
1 H-and 13 C-NMR spectra (400 and 100 MHz, respectively) were recorded on a JEOL JNM EX-400 spectrometer, with tetramethylsilane as an internal standard. Mass spectra were obtained on a JEOL JMS SX-102 spectrometer. FAB-MS were recorded using PEG-400 or m-nitrobenzyl alcohol as a matrix. UV spectra were recorded on a JASCO V-530SR spectrophotometer. IR spectra were taken on a Shimadzu IR-400 spectrophotometer or Perkin-Elmer 1720 IR FT spectrometer. Specific rotations were determined using a JASCO DIP-360 digital polarimeter. For purification, the following were used: the highly porous synthetic resin, Diaion HP-20 (Mitsubishi Chemical Co., Ltd., Tokyo), Kieselgel Extraction and Isolation Dried whole plants (111 g) were extracted with MeOH (1.8 l) at room temperature for two weeks and then refluxed twice with the same amount of MeOH. The combined MeOH extracts were concentrated in vacuo. The residue was dissolved in 90% MeOH (500 ml) and the solution was washed with n-hexane (500 mlϫ3). The 90% MeOH layer was concentrated in vacuo. The resultant residue was suspended in H 2 O (300 ml) and the suspension was extracted with EtOAc (300 mlϫ3).
The aqueous layer was chromatographed on Diaion HP-20 (60 mm in diameter and 400 mm in length). Adsorbed materials were eluted with H 2 OMeOH with a stepwise increase of MeOH. Two and one-half l of 0%, 20% and 40% MeOH in H 2 O, and MeOH were eluted, successively, and 500 ml fractions were collected. The residue (1.06 g) of fractions 9-12 was subjected to silica gel (55 g) column chromatography. Five hundred ml of each of CHCl 3 and CHCl 3 -MeOH (9 : 1, 17 : 3, 4 : 1, 7 : 3) were eluted successively. From the CHCl 3 -MeOH (17 : 3) eluate, 11 ml fractions were collected. Fractions 9-22 were combined and the residue (175.5 mg) was separated by preparative HPLC to give eustomorusside (7.7 mg) 9) and eustomoside (23.0 mg).
9) The residue (124.9 mg) of fractions 55-85 was separated by preparative HPLC to give 6Ј-O-b-D-glucopyranosylgentiopicroside (19.4 mg), 6) and swertiapunimarin (6.5 mg). 8) The residue (48.2 mg) from fractions 95-103 was separated by preparative HPLC to give septemfidoside (10.8 mg).
10)
The residue (7.85 g) of fractions 13-16 of Diaion HP-20 column chromatography was chromatographed over silica gel (150 g). CHCl 3 (1 l, fr. 1), CHCl 3 -MeOH (19 : 1)(1 l, fr 2) and CHCl 3 -MeOH (22 : 3) (300 ml, frs. 3-5) were first eluted and then CHCl 3 -MeOH (22 : 3) (700 ml), CHCl 3 -MeOH (17 : 3) (1 l) and CHCl 3 -MeOH (4 : 1) (1 l) were eluted successively, collecting 11 ml fractions. An aliquot (104.8 mg) of the residue (4.02 g) from fractions 10-100 was separated by preparative HPLC to give gentiopicroside (4) (20.0 mg) 5) and sweroside (5) (28.1 mg). 7) The residue (521.2 mg) of fractions 137-160 was separated by preparative HPLC to give olivieroside C (3) (154.5 mg). The residue (526.5 mg) of fractions 179-213 was separated by preparative HPLC to give 6Ј-O-b-D-glucopyranosyl-gentiopicroside (115.0 mg) 6) and swertiapunimarin (47.9 mg).
8)
The EtOAc layer was concentrated in vacuo to give a residue (3.71 g) which was chromatographed over silica gel (150 g) with CHCl 3 -MeOH with an increasing amount of MeOH. CHCl 3 (1 l), CHCl 3 -MeOH (1 l, 19 : 1) and CHCl 3 -MeOH (0.3 l, 9 : 1) were first eluted and then CHCl 3 -MeOH (9 : 1, 700 ml), CHCl 3 -MeOH (17 : 3, 1 l), CHCl 3 -MeOH (4 : 1, 1 l) were eluted successively, collecting 11 ml fractions. The residues (145.5 mg and 101.6 mg) of fractions 23-40 and fractions 41-49 were separated by preparative HPLC (solvent, MeOH-H 2 O, 2 : 3) to give olivieroside B (2) (12.1 mg) from the former and olivieroside A (1) (31.7 mg) from the latter.
The known compounds were identified by direct comparison of spectral data or by comparison of spectral data with those reported. The physical properties of the new compounds are as follows.
Olivieroside Olivieroside A Tetraacetate (1a) 1 (3.0 mg) was dissolved in a mixture of pyridine (0.1 ml) and Ac 2 O (0.1 ml) and the solution was kept overnight at room temperature. Excess MeOH was added to the solution and the solvent was removed in vacuo. The residue was purified by preparative TLC (solvent: Et 2 O) to give 1a (3.0 mg (1) 1 (13.6 mg) was dissolved in MeOH (2 ml), to which 1 N aqueous NaOH solution (0.2 ml) had been added. After being kept for 2 h at room temperature, the solution was neutralized with Amberlite IR-120B (H-form). The ion exchange resin was removed by filtration and the filtrate was concentrated in vacuo to give a residue which was acetylated with a mixture of pyridine (0.2 ml) and Ac 2 O (0.2 ml) for 16 h. After working up as before, the product was separated by preparative TLC (solvent: Et 2 O). The faster moving zone gave the acetate of methyl p-coumarate (4.8 mg) and the slower moving zone gave gentiopicroside tetraacetate (4a) (3.3 mg).
Methyl p- Enzymatic Hydrolysis of Olivieroside C (3) 3 (41.2 mg) was dissolved in H 2 O (5 ml), to which b-glucosidase from almond (To-yobo, Japan) (18.4 mg) had been added and the solution was kept at 37°C for 22 h. After addition of H 2 O (10 ml), the solution was extracted with EtOAc (20 ml) and the EtOAc extract was dried and evaporated in vacuo to give a residue which was purified by preparative TLC (solvent: Et 2 O) to give gentiopicral (6) (3.6 mg). Olivieroside C Heptaacetate (3a) 3 (15.3 mg) was acetylated with a mixture of Ac 2 O (0.15 ml) and pyridine (0.15 ml) as described above. The reaction product was purified by preparative TLC (solvent: Et 2 O, developed twice) to give 3a (20.9 mg) which was recrystallized from EtOH to give colorless needles, mp 158-159°C. IR n max (CHCl 3 ) cm
